Plasma Epstein-Barr virus DNA for disease surveillance in endemic nasopharyngeal carcinoma: Analysis of a real-world database
Negative EBV DNA test results have high NPVs, suggesting that patients may be routinely surveyed, while a positive result of ≥ 500 copies/mL indicates high recurrence risk.
Authors
- Joseph Wee (ORCID: https://orcid.org/0000-0001-6123-1257)
- Enya H.W. Ong (ORCID: https://orcid.org/0000-0002-2591-7910)
- Yoke Lim Soong (ORCID: https://orcid.org/0000-0003-3677-8669)
- Mei‐Kim Ang (ORCID: https://orcid.org/0000-0003-3209-864X)
- Kwok Seng Loh (ORCID: https://orcid.org/0000-0002-6324-1691)
- Sze Huey Tan (ORCID: https://orcid.org/0000-0002-3089-7379)
- Wan‐Teck Lim (ORCID: https://orcid.org/0000-0002-4655-0206)
- Jialing Neo (ORCID: https://orcid.org/0009-0002-9921-8095)
- Joshua K. Tay (ORCID: https://orcid.org/0000-0001-5653-4659)
- Melvin L.K. Chua (ORCID: https://orcid.org/0000-0002-1648-1473)
- Kam Weng Fong (ORCID: https://orcid.org/0000-0001-9745-3687)
- Xin Zhang (ORCID: https://orcid.org/0000-0001-5036-947X)
- Jianjun Liu (ORCID: https://orcid.org/0000-0002-3255-3019)
- T. Tan
- Wen Min Chow
Institutions
- National University Cancer Institute, Singapore (SG)
- National Cancer Centre Singapore (SG)
- Chongqing Cancer Hospital (CN)
- Genome Institute of Singapore (SG)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.ejca.2025.115396
- Citations
- 6
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 11.09